Twin Focus Capital Partners »

Cartesian Therapeutics shares owned by Twin Focus Capital Partners

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Twin Focus Capital Partners from 13F filings

Historical chart of Twin Focus Capital Partners investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Twin Focus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Twin Focus Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $199k 20k 10.22
2025-06-30 $197k 19k 10.39
2025-03-31 $198k 15k 13.18
2024-12-31 $215k 12k 17.91
2024-09-30 $193k 12k 16.12

More positions owned by Twin Focus Capital Partners

Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Gold Tr Ishares New (IAU)
Dell Technologies CL C (DELL)
Spdr Gold Tr Gold Shs (GLD)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Tips Bd Etf (TIP)

View all positions for Twin Focus Capital Partners

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Siren
Vanguard Group
MPM Oncology Impact Management
Erste Asset Management GmbH
Geode Capital Management
683 Capital Management
State Street Corporation
Susquehanna International
Northern Trust
Citadel Advisors
GSA Capital Partners
Marshall Wace
Royal Bank of Canada

View all funds holding Cartesian Therapeutics